PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 648 of 764

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02603081: Study to Evaluate SPI-1005 in Adults With Meniere's Disease

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00378924: Cardiology Biobank Registry

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can't Japan Cultivate Top-Tier Biotech Companies?

36KrOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GC Wellbeing clinches Korea rights to Raziel fat-shot as US phase 3 nears - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GC Green Cross Wellbeing Introduces Fat-Dissolving Injectable Ahead of U.S. Phase 3 Clinical Trials

아시아경제Original source
🇪🇸Industryrovi.esTier 1 · Company source

Informe Country by Country Público_Grupo Norbel FY25

Laboratorios RoviOriginal source
🇪🇸Industryrovi.esTier 1 · Company source

Otro información relevante

Laboratorios RoviOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bill Aims to Extend Cybersecurity Review of Made-in-China Medical Devices

mb.ntd.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BridgeBio Pharma Announces NEJM Publication and ICCBH Presentation of Positive Phase 3 PROPEL 3 Data for Oral Infigratinib in Achondroplasia

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BridgeBio's achondroplasia drug posts NEJM Phase 3 data

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Desiccant Sachets Market Growth to Accelerate by 2035 Amid Biologic Drug Expansion and Stricter Moisture Control Mandates - News and Statistics

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve paediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial

AstraZenecaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial

AstraZeneca USOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Top supplements Americans use are shifting from multivitamins to targeted health fixes

MSNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Viridian's thyroid eye disease drug wins FDA nod, squaring off with Amgen's Tepezza

FirstWord PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics Stock a No-Brainer Buy Below $35?

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The overlooked reason why new drugs take so long—and the $10 trillion fix

Fox BusinessOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nearly 1 Million Heart And Kidney Medication Bottles Recalled In Major FDA Alert

NewswavOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

“Medicine Security Is National Security”: PSGH Demands 70% Local Drug Production

Modern GhanaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical's Innovative Shift Continues With Ecopipam Addition (NYSE:TEVA)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA busts Rs 52-lakh expired food racket; FIR filed against Amazon warehouse officials

Mid-dayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Psilocybin Could Become the First FDA-Approved Psychedelic Therapy Within Months — Here Is What Patients Need to Know

Medical DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves first single-dose generic treatment for influenza

Gulf Coast MediaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

10 Best Biotech Stocks to Buy According to Analysts

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

5 Best Biotech Stocks to Buy According to Analysts

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Vytrus Biotech SA – BME:VYT

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Russian Strike Damages Kyiv Pharmaceutical Plant During Attack

Caspian PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hackensack Meridian Health Joins Phase 3 Trial of Pfizer’s Investigational C difficile Vaccine

Contagion LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Russian strike damaged Darnytsia pharmaceutical plant in Kyiv, no casualties

mezha.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves BESREMi Pen for Self-Administration in Polycythemia Vera

Oncology Nursing NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Generic Enzalutamide Tablets Granted Tentative FDA Approval for Prostate Cancer

OncLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gas Chromatography Systems Market Forecast Points Higher Toward 2035, Driven by Pharmaceutical Quality Mandates

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls

brownstone.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Conducts Surprise Inspection At Parbhani Girls Hostel Kitchen, Checks Food Safety

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Veraxa Biotech AG – NASDAQ:VRXAW

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 TRIDENT Trial Misses Survival End Point in Glioblastoma

Targeted OncologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Russians hit pharmaceutical manufacturer Darnytsia in Kyiv

YahooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Jeil Pharmaceutical Co. Ltd. – KRX:271980

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Ultragenyx Pharmaceutical Inc. – NASDAQ:RARE

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 RECONNECT Trial: ZYN002 Fails to Meet Primary Endpoint in Fragile X Syndrome Population

Vera HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Hangzhou Alltest Biotech Co., Ltd. Class A – SSE:688606

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics stock a no-brainer buy below $35?

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Kyongbo Pharmaceutical Co., Ltd. – KRX:214390

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Kyongbo Pharmaceutical Co., Ltd. – KRX:214390

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Jilin Aodong Pharmaceutical Group Co., Ltd. Class A – SZSE:000623

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Kyongbo Pharmaceutical Co., Ltd. – KRX:214390

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Jeil Pharmaceutical Co. Ltd. – KRX:271980

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Towa Pharmaceutical Co., Ltd. – TSE:4553

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Jilin Aodong Pharmaceutical Group Co., Ltd. Class A – SZSE:000623

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inside the high-stakes gamble to revive tanked biotech Opthea

AFROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of OWC PHARMACEUTICAL RESEARCH CORP – OTC:OWCP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Jeil Pharmaceutical Co. Ltd. – KRX:271980

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Jeil Pharmaceutical Co. Ltd. – KRX:271980

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Number of shareholders of Zhejiang Huahai Pharmaceutical Co., Ltd. Class A – SSE:600521

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Jeil Pharmaceutical Co. Ltd. – KRX:271980

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is the US targeting Germany's drug industry?

DW.comOriginal source